Cappelli, Laura C
Johns Hopkins University
4 papers on CoChatORCID 0000-0003-2795-7059
Most cited papers
- Verified
Society for immunotherapy of cancer (SITC) clinical practice guideline on immune checkpoint inhibitor-related adverse events
Brahmer, J. R., Abu-Sbeih, H., Ascierto, P. A., Brufsky, J., Cappelli, L. C., Cortazar, F. B., Gerber, D. E., Hamad, L., Hansen, E., Johnson, D. B., et al. (2021) · Journal for ImmunoTherapy of Cancer
Cancer Immunotherapy and BiomarkersImmunotherapy and Immune Responses
Cited by 917
- Verified
Immune checkpoint inhibitor-induced inflammatory arthritis persists after immunotherapy cessation
Braaten, T. J., Brahmer, J. R., Forde, P. M., Le, D., Lipson, E. J., Naidoo, J., Schollenberger, M., Zheng, L., Bingham, C. O., Shah, A. A., et al. (2020) · Annals of the Rheumatic Diseases
Cancer Immunotherapy and BiomarkersRheumatoid Arthritis Research and Therapies
Cited by 230
- Verified
Immune checkpoint inhibitor toxicities: systems-based approaches to improve patient care and research
Johnson, D. B., Reynolds, K. L., Sullivan, R. J., Balko, J. M., Patrinely, J. R., Cappelli, L. C., Naidoo, J., & Moslehi, J. J. (2020) · The Lancet Oncology
Cancer Immunotherapy and BiomarkersImmunotoxicology and immune responses
Cited by 118
- Verified
Association of HLA-DRB1 shared epitope alleles and immune checkpoint inhibitor-induced inflammatory arthritis
Cappelli, L. C., Dorak, M. T., Bettinotti, M. P., Bingham, C. O., & Shah, A. A. (2019) · Rheumatology
Rheumatoid Arthritis Research and TherapiesCancer Immunotherapy and Biomarkers
Cited by 111
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free